Menu
ncarol.com
  • Home
  • Business
  • Health
  • Real Estate
  • Non-profit
  • Arts
  • Transportation
  • Financial
  • Books
ncarol.com

Lineus Medical and New England Medical Specialties Announce Partnership NEMS to Distribute SafeBreak® Vascular in New England
ncarol.com/10150542

Trending...
  • MEDIA ADVISORY - Strengthening Children's Mental Health Across New Jersey
  • Growing Demand for EVA Mats Signals Shift in Car Interior Market
  • Why Philadelphia Homeowners Should Ditch Oil for Natural Gas
New England Med Spec Logo SafeBreak Vascular SafeBreak On Patient Lineus Medical
FAYETTEVILLE, Ark. - ncarol.com -- Lineus Medical, after receiving FDA clearance in May 2021 for its flagship product – SafeBreak Vascular, continues to expand its distribution network into the Northeast with the signing of New England Medical Specialties. NEMS specialize in products for I.V. Therapy, vascular access, oncology, and fall prevention. Their sales team covers Vermont, New Hampshire, Massachusetts, Rhode Island, Connecticut, and New York on behalf of Lineus Medical.

"New England Medical Specialties has provided innovative medical device solutions to our customers for over 35 years." said NEMS President Bob Proietto. "We specialize in I.V. therapy and vascular access and know that SafeBreak Vascular is going to be an important part of our product portfolio. SafeBreak Vascular is an innovative product, and we are known for bringing new technologies to the marketplace."

Lineus Medical CEO, Vance Clement, added, "When partnering with medical device distributors, we work with the best. New England Medical Specialties is the leader in their area of the country, and we are thrilled to have them represent us. Our flagship product, SafeBreak Vascular, was proven to reduce IV complications requiring an IV restart by 44% in a randomized clinical study in Hartford, CT1. Having a study conducted in New England is an impactful starting point for Bob Proietto and his team."

More on ncarol.com
  • Mensa Foundation's New Science Program Encourages Hands-On Discovery
  • Golden Paper Introduces TAD Hand Towel Technology, Ushering in a New Era of Premium Tissue Quality
  • ReedSmith® Creates Founder-Investor Connections at The Investor Dating Game™ by Tech Coast Venture Network During LA Tech Week
  • OfficeSpaces.co Expands Its AI-Powered Website Builder Across North America
  • Tobu Railway Group Will Host the Fourth Annual "Take-Akari" Bamboo Lantern Festival in East Tokyo, November 7, 2025 – January 31, 2026

SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world. The device is designed to separate when damaging force is placed on an IV line, reducing vein irritation and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient.

SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually2.

ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other  medical tubing may be reduced when a force-activated separation device is used. Learn more at www.lineusmed.com and follow us on LinkedIn or Twitter.

More on ncarol.com
  • New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks
  • Why Generic Platforms Fail in Emerging Markets: Bettorify Exposes the Gap Between Promise and Reality
  • Blogging Pioneer Sherry Bennett Celebrates 29 Years Online - Sharing the Secrets Behind Her 7-Figure Blog Empire
  • Koplon Dentistry Elevates Implant Expertise with Advanced CE Course
  • i2 Group Acquisitions and Investments in Innovations Deliver 40% Increase in Year-on-Year Bookings

1D.I.P.P.E.R Study - Data on file.
2Data on file.
3Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203

MKG-0122 Rev 0

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • GitKraken Launches Insights to Help Engineering Leaders Quantify AI Impact and Improve Developer Experience
  • ZapperBox NextGen TV Gateway Receiver Now Testing Support For Secure Whole-Home Content Distribution
  • Life as a Dog: P-Wave Press Brings Readers a Heartwarming Memoir of Love, Laughter and Companionship
  • NOYA Launches Premium, Design-Forward Training Gear That Belongs at the Center of Your Space
  • Research Defense Examines Violence, Illiteracy, Non-Active Fathers, and Low Self-Esteem Among Males
  • Investing in Greece: Your Definitive Real-Estate FAQ Guide
  • KeysCaribbean Offers 20 Percent Off Seven-Night Stays For Private Home Collection Properties
  • Advancing Circular Economy in Automotive ESD Packaging
  • Institute for Pet Health Sciences Names Boops Pets 2025 Product of the Year
  • Matthew Cossolotto, Author of The Joy of Public Speaking, Appears on "Get Authentic with Marques Ogden" and "Achieving Success with Olivia Atkin"
  • CCHR Exposes Conflicted Psychiatrists Behind Teen Antidepressant Surge
  • WIBO Announces Fall 2025 Entrepreneurship Programs to Empower NYC Founders and Small Business Owners
  • Scott Burton Releases Chaos: A Testament to the Quiet, the Final Volume in His Ten-Part Series
  • Local College Student Launches "Cleopatra" App to Make Cleaning Easy for Mercer County Residents
  • Wohler announces release of additional Balance Control output tracking for its eSeries in-rack monitor range
  • A Milestone of Giving: Ten Percent Group Donates £25,000 to Cure Parkinson's
  • Tami Goveia Enters FabOver40, Inspiring Hollywood Legacy for Breast Cancer Cause
  • Swidget Launches Luminance™ to Help Schools Achieve Alyssa's Law Compliance
  • Growing Demand for EVA Mats Signals Shift in Car Interior Market
  • MDRN MUSE Expands Insurance Network Coverage to Include Delta Dental & Cigna
_catLbl0 _catLbl1

Popular on ncarol.com

  • New Online Community Empowers Divorced Women to Build Confidence and Connection
  • CCHR: Prescription Psychotropics Fuel America's Addiction and Overdose Crisis
  • Gospel Sensation "Bible, Faith, Rembrandt aka BFR, They're Taking the World by Storm
  • AGDS Announces ALICE360 ProView EVO™
  • The Truth Behind Egypt's Stolen Legacy: Livestream
  • Cryptocurrency Trading: AHRFD Enters German Market with Institutional-Grade Infrastructure
  • Southland Symphony Orchestra Season Opener – A Musical Mosaic
  • New Jersey Therapy & Life Coaching Launches "Four Paws, Big Hearts" Fundraiser for Canine Companions
  • Keyanb Crypto Exchange Unveils Comprehensive Platform Architecture for Chilean Traders Seeking Lower Fees and Enhanced Security
  • OrderDomains.com Empowers Businesses with Premium Domains and Flexible Financing

Similar on ncarol.com

  • Mensa Foundation's New Science Program Encourages Hands-On Discovery
  • Golden Paper Introduces TAD Hand Towel Technology, Ushering in a New Era of Premium Tissue Quality
  • Koplon Dentistry Elevates Implant Expertise with Advanced CE Course
  • Avason Family Dentistry Unveils New Zygomatic Dental Implants Page
  • Pepperdine University Malibu, California and Community Partners Recognized with 2025 ReadyCommunities Partnership National Service Award
  • TKL Group's New Factory Commences Production, Pioneering A New Era In Global Heavy Duty Truck Parts
  • NOYA Launches Premium, Design-Forward Training Gear That Belongs at the Center of Your Space
  • CCHR Exposes Conflicted Psychiatrists Behind Teen Antidepressant Surge
  • Tami Goveia Enters FabOver40, Inspiring Hollywood Legacy for Breast Cancer Cause
  • MDRN MUSE Expands Insurance Network Coverage to Include Delta Dental & Cigna
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute